`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
` CATALENT PHARMA SOLUTIONS, INC.,
`Petitioner
`
`v.
`
`PATHEON SOFTGELS INC.,
`Patent Owner
`
`_____________________
`
`Case IPR2018-00422
`U.S. Pat. No. 9,693,979
`_____________________
`
`PATHEON SOFTGELS INC.’S
`UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`Patent Owner, Patheon Softgels Inc., hereby files updated mandatory notices
`
`IPR2018-00422
`U.S. Pat. No. 9,693,979
`
`pursuant to 37 C.F.R. § 42.8(a)(2).
`
`A. Real Parties in Interest (37 C.F.R. § 42.8(b)(1))
`
`The real parties-in-interest remain unchanged. The real parties-in-interest are
`
`Patheon Softgels Inc. and Thermo Fisher Scientific Inc.
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2))
`
`The related matters remain unchanged. In accordance with the Office Patent
`
`Trial Practice Guide (77 Fed. Reg. 48,756, at 48,760 (Aug. 14, 2012)), Patent Owner
`
`identifies the following related patents and applications:
`
`• U.S. Patent No. 9,693,978;
`
`• U.S. Application No. 15/591,512 filed May 10, 2017 (pending); and
`
`• U.S. Application No. 15/817,471 filed November 20, 2017 (pending).
`
`Patent Owner does not concede that any of the above-identified patent or
`
`applications would affect, or be affected by, a decision in the present inter partes
`
`review of the ’979 patent.
`
`The following judicial matters may be affected by a decision in this
`
`proceeding:
`
`• Patheon Softgels Inc., Bionpharma Inc., and Bionpharma Healthcare
`
`LLC. v. Ohm Laboratories Inc., Civ. No. 3-18-cv-00486 (D.N.J.);
`
`
`
`- 1 -
`
`
`
`IPR2018-00422
`U.S. Pat. No. 9,693,979
`• Patheon Softgels Inc., Bionpharma Inc., and Bionpharma Healthcare
`
`LLC. v. Apotex Inc. and Apotex Corp., Civ. No. 1-18-cv-00003 (D.
`
`Del.);
`
`• Patheon Softgels Inc., Bionpharma Inc., and Bionpharma Healthcare
`
`LLC. v. Apotex Inc. and Apotex Corp., Civ. No. 3-17-cv-13819
`
`(D.N.J.); and
`
`• Catalent Pharma Solutions,
`
`Inc. v. Patheon Softgels
`
`Inc.,
`
`IPR2018-00421.
`
`C. Lead and Back-Up Counsel (37 C.F.R. § 42.8(b)(3))
`
`Patent Owner designates the following lead and back-up counsel, updating
`
`email addresses:
`
`Eldora L. Ellison (Reg. No. 39,967) phone:202.772.8508
`Lead Counsel:
`Back-up Counsel: David H. Holman (Reg. No. 61,205) phone: 202.772.8989
`Back-up Counsel: David W. Roadcap (Reg. No. 68,956) phone: 202.772.8757
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`Address:
`
`1100 New York Avenue, N.W.
`Washington, DC 20005
`202.371.2600 (reception)
`202.371.2540 (facsimile)
`eellison-PTAB@sternekessler.com
`dholman-PTAB@sternekessler.com
`droadcap-PTAB@sternekessler.com
`
`
`
`
`
`
`
`
`
`
`- 2 -
`
`
`
`IPR2018-00422
`U.S. Pat. No. 9,693,979
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`D.
`
`Patent Owner consents to electronic service by email. Please direct all
`
`correspondence regarding this proceeding to the lead and back-up counsel at the
`
`addresses listed above.
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this proceeding to Deposit Account 19-0036 (Customer ID
`
`No. 45324).
`
` Respectfully Submitted,
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
` /Eldora L. Ellison/
` Eldora L. Ellison, Ph.D. (Reg. No. 39,967)
`Date: April 20, 2018
` Lead Counsel for Patent Owner
`
`
`
`
`
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`90388875.1
`
`
`
`- 3 -
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies that the above-captioned "Patheon Softgels
`
`Inc.’s Updated Mandatory Notices" was served in its entirety on April 20, 2018,
`
`upon the Petitioner via e-mail:
`
`Gregory L. Porter, Esq.
`Rose Cordero Prey, Esq.
`David Bradin, Esq.
`GregPorter@andrewskurth.com
`rprey@andrewskurthkenyon.com
`DavidBradin@andrewskurth.com
`
`
`
`
`
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
` /Eldora L. Ellison/
` Eldora L. Ellison, Ph.D. (Reg. No. 39,967)
`Date: April 20, 2018
` Lead Counsel for Patent Owner
`
`
`
`
`
`1100 New York Avenue, N.W.
`Washington, D.C.20005-3934
`(202) 371-2600
`
`
`
`
`